ClinConnect ClinConnect Logo
Search / Trial NCT06075004

Total Periarticular Infiltration Vs Posterior Periarticular Infiltration Plus PENG Block for Hip Analgesia

Launched by UNIVERSITY OF CHILE · Oct 3, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Nerve Block Periarticular Infiltration Hip Replacement Early Rehabilitation

ClinConnect Summary

This clinical trial is examining two different methods of providing pain relief after hip surgery for osteoarthritis. Researchers want to find out if a combination of two techniques—injecting local anesthetic in the back of the hip joint and using a specific nerve block—can help manage pain while preserving muscle strength better than just one method alone. The goal is to improve comfort during the first day after surgery and help patients move more easily.

To participate in this study, you should be between the ages of 18 and 80, have a healthy weight, and be in good overall health. Some people may not be eligible, such as those with certain nerve conditions, blood clotting issues, or allergies to pain medications. If you join the trial, you can expect to receive either the combined treatment or the standard one, and the team will monitor your pain and muscle strength to see which method works best. This research aims to find safer and more effective ways to manage pain after hip surgery, ultimately helping patients recover faster.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • American Society of Anesthesiologists classification 1-3
  • Body mass index between 20 and 35 (kg/m2)
  • Exclusion Criteria:
  • Adults who are unable to give their own consent
  • Pre-existing neuropathy (assessed by history and physical examination)
  • Coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work-up i.e. platelets ≤ 100, International Normalized Ratio ≥ 1.4 or prothrombin time ≥ 50)
  • Renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work-up i.e. creatinine ≥ 100)
  • Hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work-up i.e. transaminases ≥ 100)
  • Allergy to local anesthetics (LAs) or morphine
  • Pregnancy
  • Prior surgery in the inguinal area corresponding surgical side
  • Chronic pain syndromes requiring opioid intake at home

About University Of Chile

The University of Chile, a leading academic institution in South America, is dedicated to advancing medical research and improving public health through innovative clinical trials. With a strong emphasis on collaboration among multidisciplinary teams, the university leverages its extensive resources and expertise to conduct rigorous and ethically sound studies. By integrating cutting-edge scientific methodologies and fostering partnerships with healthcare providers, the University of Chile aims to contribute valuable insights to the medical community and enhance patient care both locally and globally.

Locations

Santiago, Metropolitana, Chile

Patients applied

0 patients applied

Trial Officials

Daniela Bravo, MD

Principal Investigator

University of Chile

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported